Anti-Cyclin E1 antibody [SP146]
- BOND RX™ Validated
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
3
(1 Review)
|
(7 Publications)
Rabbit Recombinant Monoclonal Cyclin E1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 7 publications.
View Alternative Names
CCNE, CCNE1, G1/S-specific cyclin-E1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin E1 antibody [SP146] (AB135380)
Immunohistochemistry analysis staining paraffin-embedded sections of human placenta tissue with ab135380 in the following dilutions : Image A : 1 : 100 dilution (2.13 μg/ml), Image B : 1 : 50 dilution (4.26 μg/ml), Image C : 1 : 50 dilution (4.26 μg/ml), Image D : Control. A ready to use secondary was used, and the counterstain was Hematoxylin. Image A and Image B : Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0) for 15mins by a pressure cooker. Image C : Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
Positive staining on the human placenta. Image A and Image B : The section was incubated with ab135380 at +4°C overnight. Image C : The section was incubated with ab135380 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin E1 antibody [SP146] (AB135380)
Immunohistochemical analysis of formalin-fixed paraffin-embedded human colon tissue labeling Cyclin E1 with ab135380 at a 1/100 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin E1 antibody [SP146] (AB135380)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human placenta tissue sections labeling Cyclin E1 with ab135380 at 1/100 dilution (2.60 µg/ml). Heat mediated antigen retrieval was performed Heat mediated antigen retrieval using sodium citrate buffer, pH 6.0. Goat Anti-Rabbit IgG H&L (HRP) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
Related conjugates and formulations (8)
-
Anti-Cyclin E1 antibody [SP146] - BSA and Azide free
-
660 APC
APC Anti-Cyclin E1 antibody [SP146]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cyclin E1 antibody [SP146]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cyclin E1 antibody [SP146]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Cyclin E1 antibody [SP146]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cyclin E1 antibody [SP146]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Cyclin E1 antibody [SP146]
-
578 PE
PE Anti-Cyclin E1 antibody [SP146]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Molecular cancer 21:171 PubMed36042494
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical and translational hepatology 10:608-619 PubMed36062277
2022
Applications
Unspecified application
Species
Unspecified reactive species
Artificial cells, nanomedicine, and biotechnology 47:896-903 PubMed30873881
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 19:967-972 PubMed30252584
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 18:455-460 PubMed29750301
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 17:5440-5448 PubMed29393456
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cancer letters 345:85-90 PubMed24333731
2013
Applications
IHC-P
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com